Where Life Sciences IP Strategy Gets Decided

Brought to you by Life Sciences Intellectual Property Review, this conference has become the definitive event for professionals navigating the intricate world of life sciences intellectual property. It's been a pivotal year for the field: the Teva v. Lilly decision has reset the rules for antibody claim strategy, the UPC's transitional opt-out window is closing fast, and the ITC is emerging as a genuine new venue for enforcement. Add a shrinking patent premium, AI tools reshaping prosecution workflows, and over $300 billion in industry revenue exposed to patent cliffs by 2030, and the decisions in-house teams make this year carry more weight than ever. Our community has grown since last year's edition, making us the place to forge new relationships, reconnect with past colleagues, and walk away with tangible tips you can apply to your everyday practice.

In an industry where robust IP valuation and protection determine the success of biopharma and medtech companies at every stage, LSPN North America Fall delivers the strategies, connections, and knowledge that drive competitive advantage. This is where innovation meets protection, where global IP strategies are forged, and where the future of life sciences intellectual property is shaped.

• Navigate the shifting regulatory and exclusivity landscape, from the latest UPC case law and preliminary injunction strategy to FDA guidance, PTEs, and biosimilar litigation risk across US and European jurisdictions.
• Master the full arc of IP deal-making, from rigorous due diligence on complex platform technologies to valuing what founders and acquirers each think their IP is worth, and structuring deals that hold up.
• Draft prosecution strategies built to survive scrutiny, sequencing clinical trial filings, optimising SPC term in Europe, and building applications that hold up against USPTO, EPO and PTAB challenge alike.
• Optimise global portfolio strategy under real budget and headcount constraints, making smarter decisions on where to file, what to maintain, and how to right-size your approach as patent cliffs and geopolitical shifts reshape the competitive landscape.
• Defend market position with an enforcement-first mindset, structuring claims for provable infringement, weighing the ITC as a fast-moving venue, and navigating post-Teva v. Lilly antibody strategy.
• Harness AI, diagnostics, and trade secret strategy to keep pace with the science, validating AI-assisted prosecution tools, protecting sequencing and diagnostic platforms, and knowing when trade secrets beat patents.

What Makes LSPN the Gold Standard

• Exclusive Access to Industry Leaders: Connect with key thought leaders and in-house decision-makers who are shaping the future of life sciences IP law.
• Cutting-Edge Content: Stay ahead of emerging patent law developments and strategies that will impact your practice and business.
• Elite Networking: Join an intimate community of the most influential patent attorneys, in-house counsel, and IP professionals in the industry.
• Global Perspective: Gain insights from international experts on maximizing IP value across global markets.